NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/06/2024
Voltar para busca
Dado oficial do USPTO
M MICROBIX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Snapshot rápido
ST13
US500000088004821Classe
1, 5, 9, 10, 42, 44, 45
Pedido
88004821
Registro
7424197
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
68
Atualização mais recente
25/06/2024
Tipo de marca
Mista
Classes Nice
1, 5, 9, 10, 42, 44, 45
Data de depósito
18/06/2018
Data de registro
25/06/2024
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/06/2024
Última transação
25/06/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
5
Tipo de titular
03
Localização do titular
Mississauga, Ontario, CA
Examinador
GOODWIN, KATRINA
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of "MICROBIX" underneath a stylized "M".
Titulares e representantes
Titulares
Microbix Biosystems Inc.
Representantes
Richard M. LaBarge MARSHALL, GERSTEIN & BORUN LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biochemical agents for in vitro and in vivo scientific or diagnostic usevirusesbacteriaparasitespurified and unpurified wholefragmentedfractionated pathogens and pathogenic organisms; Cells and cell culture derived products for in vitro or in vivo scientific or diagnostic usefor production of organismsproteinsnucleic acidscellular fractions used as reagents or antigenstest articlescontrols; antibodies and thrombolytics for in vitro scientific or research use; Biochemicals in the form of monoclonal antibodies for in vitro scientific use; Biochemicals in the form of monoclonal antibodies for research use; Active Pharmaceutical Ingredients to stimulate blood-clot dissolving processes; Microbial antigens and antisera for in vitro diagnostic use
Classe 5
urokinase used to treat blood clots; Thrombolytic drugsplasminogen activating drugs and fibrinolytic drugs; urokinase preparations for the restoration of patency to central venous catheters obstructed by clotted blood or fibrin; urokinase preparations for treating pulmonary embolism; urokinase preparations for treating the lysis of acute pulmonary emboli and pulmonary emboli accompanied by unstable hemodynamics; urokinase preparations for treating thrombosis; urokinase preparations for treating coronary artery thrombosis; urokinase preparations for treating myocardial infarction; urokinase preparations for the lysis of thrombi; urokinase preparations for treating peripheral arterial and graft thromboembolic occlusion; urokinase preparations for treating deep vein thrombosis; urokinase preparations for treating pleural effusions; urokinase preparations for treating peripheral arterial occlusion; urokinase preparations for treating ischemic stroke; urokinase preparations for treating lower limb ischemia; test samples used in conjunction with laboratory diagnostics in the nature of biological or biochemical samples used to verify the reliability of laboratory equipment; test samples used in conjunction with assay methods in the nature of biological or biochemical assay samples used to verify the reliability of laboratory tests; Liquidfrozen and lyophilized inactivatednative pathogensincluding whole and fragmented eukaryotesprokaryotesvirusesindependent and in host cellsall for in vitro and in vivo scientific or diagnostic use; inactivatednative pathogensliquidfrozen or lyophilized recombinant DNA and/or RNA preparationseither purified or within host organismsin various bufferssingly and in combinationall for in vitro and in vivo scientific or diagnostic use; Positive controlsreagents for use with nucleic-acid-basedimmunologicother diagnostic tests to confirm proper test operationrun in conjunction with patient samples run to confirmassesstestverify the operation of the test method; proficiency test samples in the nature of biological test samples used to test the proficiency of technicians who use infectious disease diagnostics test systems to determine the pathogenic or biochemical content of samples; Diagnostic reagents in the nature of biotechnology products for medical and veterinary usemicro-organisms for amplification controls; Diagnostic kits for in-vitro scientific and diagnostic use; Laboratory assay kits for scientific and diagnostic use; Biological material for scientific or diagnostic purposesin the nature of serum and plasma from infected and disease state individuals used for verification and validation of human diagnostic assays for such infections and diseases; Biotechnology products for scientific or diagnostic purposesreagents and solutions in the nature of virusesbacteriafungiparasitesderivatives thereof used to researchdevelopmanufacturevalidate infectious disease diagnostic tests; biochemical productsantibodies for scientific or research use; diagnostic reagents containing lyophilized microorganismsreagents containing lyophilized microorganisms all for in-vitro use and for use in biochemistryclinical chemistry and microbiology; diagnostic reagents for scientific research use; diagnostic reagents for medical research use; diagnostic preparations for clinical laboratory use; diagnostic preparations for medical laboratory use; diagnostic preparations for medical research use; diagnostic preparations for scientific research use
Classe 9
laboratory instruments for the detection pathogens and toxins in a biological sample for research use; Instruments for the processing of cells and cell derived materialsflow cytometers and flow-based analyzers that detect and analyze nucleic acid content for scientificlaboratorygeneral research use; laboratory instruments that detect pathogens in a biological sample for research use; Instruments for the processing of cells and cell derived materials
Classe 10
automated flow cytometer sample introduction accessories used in conjunction with a flow cytometer to deliver biological and chemical samples from single test tubes and multiwell laboratory plates; medical apparatus for the automated analysis of cells in the nature of cytometers for medical diagnostic use; medical apparatus for the automated cytometric analysis of cells in the nature of cytometers for medical diagnostic use; medical apparatus in the nature of cytometers that detect atypia in cells for medical diagnostic use; medical apparatus for automated analysis of nuclear features for the detection of neoplasms and cancer and genetic conditions; apparatus for medical diagnostic uses in the nature of an automated flow cytometer sample introduction accessorya machine which is used in conjunction with a flow cytometer to deliver biological and chemical samples from single test tubes and multi-well laboratory plates
Classe 42
Providing diagnostic testing serviceslaboratory tests; production for others of cellscell linesvirusesbacteriapathogensproteinsnucleic acids in whole or in part; Research and development services in the field of process technology used in the manufacture of vaccines; process technology services to be used in the manufacture of a vaccine; biological cell-selection services for biological research purposes; biological research services of delivering energy to a population of biological cells for the purpose of selecting desired cells and negatively selecting undesired cells
Classe 44
Animal husbandry services; animal breeding services; sperm- and semen-sexing services in the nature of in vitro fertilization services; biological cell-selection services for medical purposes in the nature of in vitro fertilization services; medical services in the field of in vitro fertilizationservices of delivering energy to a population of biological cells for the purpose of selecting desired cells and negatively selecting undesired cells
Classe 45
Licensing of process technology used in the manufacturing of vaccines
Publicações
Histórico de despachos e eventos da marca no USPTO.
68 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
25/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/04/2024
PUBO
PUBLISHED FOR OPPOSITION
09/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/03/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/02/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
20/02/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/02/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
20/02/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
28/12/2023
GNRT
NON-FINAL ACTION E-MAILED
28/12/2023
CNRT
NON-FINAL ACTION WRITTEN
28/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/10/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
24/10/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
26/07/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
26/07/2023
CNSI
SUSPENSION INQUIRY WRITTEN
26/07/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/07/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
14/12/2022
GNSL
LETTER OF SUSPENSION E-MAILED
14/12/2022
CNSL
SUSPENSION LETTER WRITTEN
14/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/12/2022
ALIE
ASSIGNED TO LIE
12/12/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/12/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/06/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/06/2022
CNSI
SUSPENSION INQUIRY WRITTEN
09/06/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
25/05/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
20/10/2021
GNSL
LETTER OF SUSPENSION E-MAILED
20/10/2021
CNSL
SUSPENSION LETTER WRITTEN
20/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/10/2021
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/04/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/04/2021
CNSI
SUSPENSION INQUIRY WRITTEN
08/04/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
24/03/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/06/2020
GNSL
LETTER OF SUSPENSION E-MAILED
12/06/2020
CNSL
SUSPENSION LETTER WRITTEN
12/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/06/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/06/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/12/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/12/2019
CNSI
SUSPENSION INQUIRY WRITTEN
09/12/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/12/2019
ALIE
ASSIGNED TO LIE
15/11/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
24/04/2019
GNSL
LETTER OF SUSPENSION E-MAILED
24/04/2019
CNSL
SUSPENSION LETTER WRITTEN
24/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/04/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/10/2018
GNRT
NON-FINAL ACTION E-MAILED
10/10/2018
CNRT
NON-FINAL ACTION WRITTEN
10/10/2018
DOCK
ASSIGNED TO EXAMINER
04/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/06/2018
NWAP
NEW APPLICATION ENTERED
21/06/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace M MICROBIX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.